Navigation Links
Carrington Reports 2007 Financial Results
Date:3/31/2008

Company Cites Important Progress With Needle-free Vaccine Technology and

Bird Flu Clinical Program Webcast/teleconference Call Set for 4:30 pm Today, Monday March 31, 2008

IRVING, Texas, March 31 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (OTC Bulletin Board: CARN) today reported revenue of $21.8 million and a net loss of $9.8 million, or ($0.90) per basic and diluted share, for the year ended December 31, 2007.

Excluding net funding of $2.8 million for DelSite Biotechnologies, Inc., the Company's wholly-owned drug delivery subsidiary, the pro forma loss for 2007 was $7.0 million. 2006's net loss, including DelSite net costs of $3.1 million, was $7.6 million, or ($0.70) per basic and diluted share, on Company- wide revenue of $27.4 million.

The decrease in revenue for 2007 was primarily due to a decrease in consumer services revenue, to $11.6 million from $16.6 million a year ago. Medical services revenues dropped slightly, to $8.4 million from $8.8 million in 2006; royalty income remained roughly the same at $417,000.

Revenue for the fourth quarter ended December 31, 2007 decreased to $5.0 million from $6.7 million in the year-ago period. The net loss for the quarter was $2.7 million, or ($0.25) per basic and diluted share. The pro forma loss, before accounting for net expenses of DelSite, was $2.1 million. The year-ago fourth quarter's final net loss, including DelSite net expenses of $622,000, was $2.2 million, or ($0.20) per basic and diluted share.

"While our consumer services revenue base continues to be under pressure due to general economic conditions and lower order flow from our historically largest customer, we are stabilizing our revenue base in medical services. I am excited about the advances being made in the three technology platforms and the typhoid antigen being developed by DelSite. As previously stated, DelSite is currently engaged in the cGMP manufacture of the H5N
'/>"/>

SOURCE Carrington Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
2. Carrington Reports Second Quarter 2007 Results
3. Carrington Completes $8 Million Financing
4. Carrington Reports on ISO 9001:2000 Inspection at Sabila Industrial in Costa Rica
5. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
6. Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market
7. Carrington Laboratories Common Stock Now Trading on the OTC Bulletin Board: CARN.OB
8. Carrington Reports on ISO 9001:2000 Inspection
9. Carrington Reports Third Quarter 2007 Results
10. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
11. Carrington Settles Lawsuit, Sets Sights On Future

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009).... 3 ACCESS PHARMACEUTI...rovided an update on its European commercial launc...cositis, a debilitating side effect of radiation t...launched by Access, partner, SpePharm, in six Euro...Norway, Greece and Sweden. Access is conducting pr...
(Date:12/3/2009)...., Dec. 3 Caliper Life S... of tools and services for drug discovery and life...4.0 software for IVIS® in vivo imaging system...Caliper IVIS systems currently installed in labora...ed spectral unmixing tools to enhance fluorescent ...
(Date:12/2/2009)...Dec. 2 Reportlinker.com announces ...its catalogue: ,, Carbondioxide Incubators - A...rtlinker.com/p0164368/Carbondioxide-Incubators---A... are the most critical equipment used in microbiol...tions for providing a controlled environment to gr...
(Date:12/2/2009)...ec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech ...DAQ: ONCY ) announced today that in connection wit...rwriters have exercised in full their over-allotme...s. Each unit is comprised of one common share and ...ld at a price of US$3.00 per unit. Each whole comm...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4
...nds Company Initial $250,000 under March ...ril 22 bioMETRX Inc., (OTC,Bulletin Board: BMRX),...d,finger-activated products, today announced that ...sets and former personnel of Sequiam,Corporation (...nounced,agreement with Biometric Investors, LLC., ...
...22 Renovis, Inc.,(Nasdaq: RNVS ), today announce... firm, has joined ISS/Risk Metrics in recommending...greement with Evotec AG (Frankfurt,Stock Exchange:...d for May,1, 2008. In the proposed merger, each sh... the right to receive the equivalent of 1.0542 Evo...
...rement helps physicians guide therapy for ...GHAM, Ala., April 22 The determination of LDL,non...e and recommended,methods of guiding and achieving...metabolic risk (CMR). The VAP(R) Cholesterol Test ...ble advanced lipid profile that routinely,reports ...
Other Biology Technology:bioMETRX, Inc. Initiates Integration of Personnel and Assets of Sequiam Corp. 2Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec 2Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec 3Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients 2Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients 3
(Date:12/3/2009)...year record low in Antarctic snowmelt that occurre... to concurrent strong positive phases for two main...ion) and SAM (Southern Hemisphere Annular Mode), a... of Earth & Atmospheric Sciences at The City Colle...so on the doctoral faculty at the CUNY Graduate Ce...
(Date:12/2/2009)...LADELPHIA Less acculturated Latino men have a mor...re more acculturated to U.S. culture, but accultur...oking. Details of these findings are published in ...journal of the American Association for Cancer Res...obacco. , "Acculturation affects smoking cessati...
(Date:12/2/2009)...DELPHIA Cigarette smoking and alcohol consumption...edicts the patient,s future risk of death, accordi...dy show a similar effect among those who continued...ncer survivors are counseled to quit smoking; desp...nt continued to smoke even after their cancer diag...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Acculturation affects smoking cessation success among Latinos 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2The tourist trap 9540 1Capping a two faced particle gives duke engineers complete control 13514 1Capping a two faced particle gives duke engineers complete control 13514 2Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies 13513 1Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies 13513 2Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies 13513 3
...s and a common heavy metal are unable to obtain su... according to a new study presented at The America...ysiology 2006. , The study showed how cadmium, a ...mer water temperatures and makes it more vulnerabl...Half of the oysters exposed to the pollutant in 28...
...apeutic drugs specifically targets mutant enzymes ...te uncontrolled cell growth. As promising as these...the wall have the tendency to fight back. A major ... of cellular desperation. , In a forthcoming issue...te for Biological Studies uncover one means cancer...
...differences among female Glanville fritillary butt...irth place and establish new colonies. These ventu...ce more quickly compared to their less mobile fema...ic differences influence behavior and how the envi...viduals with certain traits, said lead author Howa...
Other Biology News:Rising ocean temperatures, pollution have oysters in hot water 2Rising ocean temperatures, pollution have oysters in hot water 3Rising ocean temperatures, pollution have oysters in hot water 4Distinguishing friend from foe in the battle against cancer 2Distinguishing friend from foe in the battle against cancer 3Some butterflies travel farther, reproduce faster 2Some butterflies travel farther, reproduce faster 3
...and 135 S steam sterilizers with their ultra-flat ...he advantages of a double-walled device - low ener...ve deaeration and drying by built-in jacket heater...ng. The chamber is free of furnishings and feed wa...
...Console Orbital Shakers combine high durability an...alled programming power. The patented triple-coun...n, allowing the unit to run with heavy out-of-bala...duces contamination. The heavy stainless steel in...
SagaGT Microsatellite Analysis Software (Server edition) from LI-COR Biosciences
...rray CGH Genomic Labeling Systems are a high-perfo...ling of genomic DNA samples for array-based Compar...th indirect and direct labeling formats, the BioPr...e a flexible solution to your genomic labeling nee...
Biology Products: